New Releases from NCBI BookshelfAbiraterone (originator and generics) for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer.​Abiraterone (originator and generics) for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer.